{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:24:52Z","timestamp":1790425492539,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"8","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejim.2013.05.015","type":"journal-article","created":{"date-parts":[[2013,6,20]],"date-time":"2013-06-20T08:16:43Z","timestamp":1371716203000},"page":"721-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"title":["Clinical indications for the albumin use: Still a controversial issue"],"prefix":"10.1016","volume":"24","author":[{"given":"Paolo","family":"Caraceni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Domenicali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tovoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen Serena","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Tufoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.05.015_bb0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1093\/protein\/12.6.439","article-title":"Crystal structure of human serum albumin at 2.5A resolution","volume":"12","author":"Sugio","year":"1999","journal-title":"Protein Eng"},{"key":"10.1016\/j.ejim.2013.05.015_bb0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15216540500404093","article-title":"The extraordinary ligand binding properties of human serum albumin","volume":"57","author":"Fasano","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ejim.2013.05.015_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2036.16.s5.2.x","article-title":"Review article: albumin as a drug\u2013biological effects of albumin unrelated to oncotic pressure","volume":"16","author":"Evans","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2013.05.015_bb0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness","volume":"85","author":"Nicholson","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.ejim.2013.05.015_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0035","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0040","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjp.0707251","article-title":"Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties","volume":"151","author":"Oettl","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ahj.2009.12.026","article-title":"Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study","volume":"159","author":"Van Belle","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2013.05.015_bb0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1096\/fasebj.13.2.233","article-title":"Glucose and free radicals impair the antioxidant properties of serum albumin","volume":"13","author":"Bourdon","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.ejim.2013.05.015_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/CS20070276","article-title":"Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin","volume":"114","author":"Faure","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ejim.2013.05.015_bb0060","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1081\/JDI-100104738","article-title":"Oxidation of albumin is enhanced in the presence of uremic toxins","volume":"23","author":"Wratten","year":"2001","journal-title":"Ren Fail"},{"key":"10.1016\/j.ejim.2013.05.015_bb0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1523-1755.2001.00807.x","article-title":"Albumin is the major plasma protein target of oxidant stress in uremia","volume":"60","author":"Himmelfarb","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2013.05.015_bb0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbadis.2008.04.002","article-title":"Oxidative damage of albumin in advanced liver disease","volume":"1782","author":"Oettl","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejim.2013.05.015_bb0075","article-title":"Human nonmercaptalbumin-2: a novel prognostic marker in chronic liver failure","author":"Stauber","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.ejim.2013.05.015_bb0080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1432-1033.1994.tb18614.x","article-title":"Involvement of a lysine residue in the N-terminal Ni2+ and Cu2+ binding site of serum albumins. Comparison with Co2+, Cd2+ and Al3+","volume":"220","author":"Sadler","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ejim.2013.05.015_bb0085","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jinorgbio.2009.04.011","article-title":"Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin","volume":"103","author":"Soko\u0142owska","year":"2009","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.ejim.2013.05.015_bb0090","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1172\/JCI116364","article-title":"NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties","volume":"91","author":"Keaney","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejim.2013.05.015_bb0095","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0272-6386(99)70306-9","article-title":"Effect of increasing serum albumin on plasma D-dimer, von Willebrand factor, and platelet aggregation in CAPD patients","volume":"33","author":"Kim","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2013.05.015_bb0100","doi-asserted-by":"crossref","first-page":"73A","DOI":"10.1111\/j.1530-0277.1996.tb01735.x","article-title":"Role of albumin and high-density lipoprotein as endotoxin-binding proteins in rats with acute and chronic alcohol loading","volume":"20","author":"Kitano","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ejim.2013.05.015_bb0105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/00365520902719273","article-title":"Effect of intravenous albumin on endotoxin removal, cytokines, and nitric oxide production in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"44","author":"Chen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0110","doi-asserted-by":"crossref","first-page":"C439","DOI":"10.1152\/ajpcell.1993.265.2.C439","article-title":"Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix","volume":"265","author":"Qiao","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200401000-00012","article-title":"Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium","volume":"100","author":"Lang","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0120","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0168-8278(00)00009-X","article-title":"Dynamics of albumin in plasma and ascitic fluid in patients with cirrhosis","volume":"34","author":"Henriksen","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0125","first-page":"412","article-title":"Ascites kinetics in cirrhosis: relationship to plasma-ascites hydrostatic\u2013oncotic balance and intensity of renal sodium retention","volume":"107","author":"Rector","year":"1986","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0130","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0135","first-page":"44","article-title":"Cardiovascular complications of cirrhosis","volume":"85","author":"M\u00f8ller","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2013.05.015_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/cc11218","article-title":"Human albumin in the management of complications of liver cirrhosis","volume":"16","author":"Bernardi","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.ejim.2013.05.015_bb0145","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0150","author":"Runyon"},{"key":"10.1016\/j.ejim.2013.05.015_bb0155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0160","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0165","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840130416","article-title":"Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites","volume":"13","author":"Salerno","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0170","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gin\u00e8s","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0175","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/jhep.2003.50169","article-title":"Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites","volume":"37","author":"Sola-Vera","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0180","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0168-8278(00)80201-9","article-title":"Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club","volume":"32","author":"Rimola","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0190","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040319","article-title":"Bacterial infections, sepsis, and multiorgan failure in cirrhosis","volume":"28","author":"Tandon","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejim.2013.05.015_bb0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.2006.113050","article-title":"Restricted use of albumin for spontaneous bacterial peritonitis","volume":"56","author":"Sigal","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2013.05.015_bb0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1478-3231.2008.01877.x","article-title":"Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study","volume":"29","author":"Terg","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.ejim.2013.05.015_bb0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cgh.2011.11.012","article-title":"Role of albumin treatment in patients with spontaneous bacterial peritonitis","volume":"10","author":"Poca","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0220","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/gutjnl-2011-301739","article-title":"Low-dose albumin in the treatment of spontaneous bacterial peritonitis: should we change the standard treatment?","volume":"61","author":"De Araujo","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2013.05.015_bb0225","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0230","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2013.05.015_bb0235","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0240","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0245","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0250","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0255","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0260","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome","volume":"9","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2013.05.015_bb0265","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(99)80194-9","article-title":"Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial","volume":"30","author":"Gentilini","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0270","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0275","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0280","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/hep.22418","article-title":"Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management","volume":"48","author":"Gin\u00e8s","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.317.7153.235","article-title":"Human albumin administration in critically ill patients: systematic review of randomised controlled trials. Cochrane Injuries Group Albumin Reviewers","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2013.05.015_bb0290","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-135-3-200108070-00007","article-title":"Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials","volume":"135","author":"Wilkes","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0295","first-page":"CD001208","article-title":"Human albumin solution for resuscitation and volume expansion in critically ill patients","author":"Alderson","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2013.05.015_bb0300","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0305","first-page":"CD001208","article-title":"Human albumin solution for resuscitation and volume expansion in critically ill patients","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2013.05.015_bb0310","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJMoa067514","article-title":"Saline or albumin for fluid resuscitation in patients with traumatic brain injury","volume":"357","author":"Myburgh","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0315","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00134-010-2039-6","article-title":"Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis","volume":"37","author":"Finfer","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0320","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/CCM.0b013e3181ffe217","article-title":"The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis","volume":"39","author":"Delaney","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ejim.2013.05.015_bb0330","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2013.05.015_bb0335","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1572-0241.2005.40864.x","article-title":"Emerging indications for albumin dialysis","volume":"100","author":"Sen","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0340","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-011-2058-8","article-title":"The role of molecular adsorbent recirculating system dialysis for extracorporeal liver support in children","author":"Schaefer","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0345","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.3748\/wjg.v17.i30.3479","article-title":"How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure","volume":"17","author":"Mirici-Cappa","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2013.05.015_bb0350","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/ajhp\/60.13.1330","article-title":"Evaluation of the appropriate use of albumin in adult and pediatric patients","volume":"60","author":"Tanzi","year":"2003","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejim.2013.05.015_bb0355","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1345\/aph.19385","article-title":"Costs related to inappropriate use of albumin in Spain","volume":"34","author":"Tar\u00edn Remoh\u00ed","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2013.05.015_bb0360","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1008635005398","article-title":"Clinical practice guidelines for the use of albumin: results of a drug use evaluation in a Paris hospital. Tenon Hospital Paris","volume":"21","author":"Debrix","year":"1999","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.ejim.2013.05.015_bb0365","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s002280050320","article-title":"Use of albumin in two Spanish university hospitals","volume":"52","author":"Vargas","year":"1997","journal-title":"Eur J Clin Pharmacol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051300143X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051300143X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T20:34:07Z","timestamp":1595968447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362051300143X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S095362051300143X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.05.015","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical indications for the albumin use: Still a controversial issue","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}